Src/caveolin-1-regulated EGFR activation antagonizes TRAIL-induced apoptosis in gastric cancer cells

Xu,Ling; Qu,Xiujuan; Li,Heming; Li,Ce; Liu,Jing; Zheng,Huachuan; Liu,Yunpeng

doi:10.3892/or.2014.3183

Src/caveolin-1-regulated EGFR activation antagonizes TRAIL-induced apoptosis in gastric cancer cells

Authors:
- Ling Xu
- Xiujuan Qu
- Heming Li
- Ce Li
- Jing Liu
- Huachuan Zheng
- Yunpeng Liu
View Affiliations

Affiliations: Department of Medical Oncology, The First Hospital of China Medical University, Heping, Shenyang 110001, P.R. China, Cancer Research Center, The First Affiliated Hospital of Liaoning Medical University, Jinzhou, Liaoning 121001, P.R. China
Published online on: May 15, 2014 https://doi.org/10.3892/or.2014.3183
Pages: 318-324

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Gastric cancer cells are insensitive to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), and we recently showed that lipid raft-regulated epidermal growth factor receptor (EGFR) activation antagonized TRAIL-induced apoptosis. However, it is not clear whether caveolin-1, an essential structural constituent of lipid rafts, regulates lipid raft-mediated EGFR activation. We report here that TRAIL induced the translocation of EGFR into lipid rafts and its activation in gastric cancer SGC-7901 and MGC-803 cells. Simultaneously, caveolin-1 was also activated. Knockdown of caveolin-1 partially prevented EGFR activation and increased TRAIL sensitivity. Moreover, TRAIL promoted the translocation of Src into lipid rafts and its activation, as well as the interaction of Src with both EGFR and caveolin-1. A Src inhibitor prevented these interactions and the activation of caveolin-1 and EGFR, and thus enhanced TRAIL-induced apoptosis. These data suggest that Src activates EGFR through the interaction of both Src-EGFR and Src-caveolin-1, and then antagonizes TRAIL-induced apoptosis in gastric cancer cells.

View Figures

View References

1	Cervantes A, Roda D, Tarazona N, Roselló S and Pérez-Fidalgo JA: Current questions for the treatment of advanced gastric cancer. Cancer Treat Rev. 39:60–67. 2013. View Article : Google Scholar : PubMed/NCBI
2	Schaefer U, Voloshanenko O, Willen D and Walczak H: TRAIL: a multifunctional cytokine. Front Biosci. 12:3813–3824. 2007. View Article : Google Scholar : PubMed/NCBI
3	Morizot A, Mérino D, Lalaoui N, et al: Chemotherapy overcomes TRAIL-R4-mediated TRAIL resistance at the DISC level. Cell Death Differ. 18:700–711. 2011. View Article : Google Scholar : PubMed/NCBI
4	Xu L, Qu X, Luo Y, et al: Epirubicin enhances TRAIL-induced apoptosis in gastric cancer cells by promoting death receptor clustering in lipid rafts. Mol Med Rep. 4:407–411. 2011.
5	Cho IR, Koh SS, Min HJ, et al: Reovirus infection induces apoptosis of TRAIL-resistant gastric cancer cells by down-regulation of Akt activation. Int J Oncol. 36:1023–1030. 2010.PubMed/NCBI
6	Van Schaeybroeck S, Kelly DM, Kyula J, Stokesberry S, Fennell DA, Johnston PG and Longley DB: Src and ADAM-17-mediated shedding of transforming growth factor-α is a mechanism of acute resistance to TRAIL. Cancer Res. 68:8312–8321. 2008.PubMed/NCBI
7	Xu L, Zhang Y, Liu J, et al: TRAIL-activated EGFR by Cbl-b-regulated EGFR redistribution in lipid rafts antagonises TRAIL-induced apoptosis in gastric cancer cells. Eur J Cancer. 48:3288–3299. 2012. View Article : Google Scholar : PubMed/NCBI
8	Wang S, Yu S, Shi W, Ge L, Yu X, Fan J and Zhang J: Curcumin inhibits the migration and invasion of mouse hepatoma Hca-F cells through down-regulating caveolin-1 expression and epidermal growth factor receptor signaling. IUBMB Life. 63:775–782. 2011.
9	Zhang B, Peng F, Wu D, Ingram AJ, Gao B and Krepinsky JC: Caveolin-1 phosphorylation is required for stretch-induced EGFR and Akt activation in mesangial cells. Cell Signal. 19:1690–1700. 2007. View Article : Google Scholar : PubMed/NCBI
10	Zhang J, Kalyankrishna S, Wislez M, et al: SRC-family kinases are activated in non-small cell lung cancer and promote the survival of epidermal growth factor receptor-dependent cell lines. Am J Pathol. 170:366–376. 2007. View Article : Google Scholar : PubMed/NCBI
11	Wu T, Zhang B, Ye F and Xiao Z: A potential role for caveolin-1 in VEGF-induced fibronectin upregulation in mesangial cells: involvement of VEGFR2 and Src. Am J Physiol Renal Physiol. 304:F820–F830. 2013. View Article : Google Scholar : PubMed/NCBI
12	Chen Z, Bakhshi FR, Shajahan AN, et al: Nitric oxide-dependent Src activation and resultant caveolin-1 phosphorylation promote eNOS/caveolin-1 binding and eNOS inhibition. Mol Biol Cell. 23:1388–1398. 2012. View Article : Google Scholar : PubMed/NCBI
13	Wang Y, Roche O, Xu C, et al: Hypoxia promotes ligand-independent EGF receptor signaling via hypoxia-inducible factor-mediated upregulation of caveolin-1. Proc Natl Acad Sci USA. 109:4892–4897. 2012. View Article : Google Scholar : PubMed/NCBI
14	Xu L, Qu X, Zhang Y, et al: Oxaliplatin enhances TRAIL-induced apoptosis in gastric cancer cells by CBL-regulated death receptor redistribution in lipid rafts. FEBS Lett. 583:943–948. 2009. View Article : Google Scholar : PubMed/NCBI
15	Irwin ME, Mueller KL, Bohin N, Ge Y and Boerner JL: Lipid raft localization of EGFR alters the response of cancer cells to the EGFR tyrosine kinase inhibitor gefitinib. J Cell Physiol. 226:2316–2328. 2011. View Article : Google Scholar : PubMed/NCBI
16	Dittmann K, Mayer C, Kehlbach R and Rodemann HP: Radiation-induced caveolin-1 associated EGFR internalization is linked with nuclear EGFR transport and activation of DNA-PK. Mol Cancer. 7:692008. View Article : Google Scholar : PubMed/NCBI
17	Sham D, Wesley UV, Hristova M and van der Vliet A: ATP-mediated transactivation of the epidermal growth factor receptor in airway epithelial cells involves DUOX1-dependent oxidation of Src and ADAM17. PLoS One. 8:e543912013. View Article : Google Scholar : PubMed/NCBI
18	De Luca A, D’Alessio A, Gallo M, Maiello MR, Bode AM and Normanno N: Src and CXCR4 are involved in the invasiveness of breast cancer cells with acquired resistance to lapatinib. Cell Cycle. 13:148–156. 2014.PubMed/NCBI
19	Samarakoon R, Chitnis SS, Higgins SP, Higgins CE, Krepinsky JC and Higgins PJ: Redox-induced Src kinase and caveolin-1 signaling in TGF-β1-initiated SMAD2/3 activation and PAI-1 expression. PLoS One. 6:e228962011.PubMed/NCBI
20	Dittmann K, Mayer C, Kehlbach R, Rothmund MC and Peter Rodemann H: Radiation-induced lipid peroxidation activates src kinase and triggers nuclear EGFR transport. Radiother Oncol. 92:379–382. 2009. View Article : Google Scholar : PubMed/NCBI
21	Gottlieb-Abraham E, Shvartsman DE, Donaldson JC, Ehrlich M, Gutman O, Martin GS and Henis YI: Src-mediated caveolin-1 phosphorylation affects the targeting of active Src to specific membrane sites. Mol Biol Cell. 24:3881–3895. 2013. View Article : Google Scholar : PubMed/NCBI
22	Chen J, Chen JK and Harris RC: Angiotensin II induces epithelial-to-mesenchymal transition in renal epithelial cells through reactive oxygen species/Src/caveolin-mediated activation of an epidermal growth factor receptor-extracellular signal-regulated kinase signaling pathway. Mol Cell Biol. 32:981–991. 2012. View Article : Google Scholar